Navigation Links
ISTA Pharmaceuticals Announces Physician-Sponsored Clinical Study of Xibrom(TM) Combination Therapy with Lucentis(R)
Date:2/22/2008

Presentation is One of Five Posters Scheduled for the 2008 Annual Meeting

of the Association for Research in Vision and Ophthalmology (ARVO)

IRVINE, Calif., Feb. 22 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced today the acceptance of an abstract describing the results of a study using Xibrom(TM) (bromfenac ophthalmic solution) 0.09% therapy in combination with Lucentis(R) (ranibizumab injection) in patients with age-related macular degeneration (AMD). According to the abstract, patients who received Xibrom required 1.6 +/- 0.69 injections of Lucentis during the six-month study period, while patients who received only Lucentis received 4.5 +/- 0.41 injections. Patients with Lucentis alone received significantly more (2.83 times) injections of ranibizumab (p=0.0002) than those receiving the combination. There was a numerical trend in favor of the combination treatment group on improvement in visual acuity but this difference did not achieve statistical significance. These data are expected to be presented at the ARVO 2008 annual meeting, which begins at the end of April.

The study results were gathered from 60 patients receiving Lucentis therapy for wet AMD. Patients were monitored monthly using optical coherence tomography (OCT) and fluorescein angiography. When leakage from vessels was detected, patients were re-injected with Lucentis. 30 patients received Xibrom dosed twice daily in addition to the Lucentis injection, and their results were compared to 30 patients who received Lucentis only. There were no adverse events associated with the extended topical administration of bromfenac. The study was designed as a retrospective case control series.

The clinical findings will be pre
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
2. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
3. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
4. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
5. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
6. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
7. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
8. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
10. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
11. Cogentus Pharmaceuticals Begins Clinical Study to Confirm the Full Antiplatelet Benefit of New Combination Medicine CGT-2168
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. , ... Complete EHR certification, which designates that the software is ... 1 and Stage 2 Meaningful Use measures required to ... Act (ARRA).  ONETOUCH EMR 2.0 was certified on July ... of the National Coordinator-Authorized Certification Body (ONC-ACB) and is ...
(Date:9/17/2014)... 17, 2014  Millions of people suffer from neck and ... Recently the FDA approved the launch of a ... implant device developed by Spinal Kinetics, which may offer relief ... or arm pain. Hospital for Special Surgery (HSS), the number ... in New York City and in ...
(Date:9/17/2014)... Sept. 17, 2014   MedeAnalytics today ... that brings complete visibility to a provider,s "mid-cycle" ... ever-evolving reimbursement landscape. Powered by the industry,s leading ... the critical point between patient access and the ... solution will improve revenue capture, minimize audit risk ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Cervical Disc Clinical Trial for People with Neck and Arm Pain Set to Begin at Hospital for Special Surgery 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3
... recalls increased more than 160 percent in the first ... many units than the previous quarter, according to the ... impacted by the increase include alcohol prep pads, catheters, ... in the first quarter of 2012. Conversely, the ExpertRECALL ...
... May 14, 2012  DICOM Grid announced today it has ... Herring,s Top 100 Americas award, a prestigious list honoring ... North American business region. The Red ... a pool of hundreds from across North America. The ...
Cached Medicine Technology:Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 2Medical Device Recalls Soar During First Quarter, ExpertRECALL Index Shows 3DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award 2
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- A blood ... could provide doctors with a better assessment of the ... If used routinely, this blood test could ... working and actually begins promoting tumor growth, the researchers ... given to patients with advanced prostate cancer and often ...
(Date:9/17/2014)... at The Scripps Research Institute (TSRI) have devised ... powerfully effective against vancomycin-resistant strains of MRSA and ... appears to have not one but two distinct ... cannot evolve resistance quickly. , "This is the ... be in clinical use a generation or maybe ...
(Date:9/17/2014)... 2014 Prevention is the best treatment ... scores of infants, children and teenagers in 12 states, ... medical director of Legacy ER & Urgent Care (LER) ... reported cases of EV-D68 so far in North Texas, ... change,” he said. “Implementing prevention strategies now may help ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 Many countries ... influenza, instead of immunizations. The total number of poultry ... difficult to control, will result in huge losses. Therefore, ... avian influenza vaccines. , Avian influenza vaccines have been ... poultry farms in China began to use H5N1 avian ...
(Date:9/17/2014)... 2014 The Food and Drug Administration ... 2014, to consider: , 1. The ... 2. The potential for adverse cardiovascular ... TRT litigation ongoing, an informally-organized litigation group subcommittee prepared ... testosterone replacement therapy. Among others, ZKB attorney Michelle L. ...
Breaking Medicine News(10 mins):Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 3Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2
... cannot control their conditions with medications need not worry now ... for their rescue. ,The new device ... the University of Rochester Medical Center as part of a ... significant reduction in the blood pressure in patients suffering from ...
... one in 10 U.S. adults suffer chronic pain that lasts a ... increased to a record average of just short of 80 years, ... Centers for Disease Control and Prevention. ,The CDC said, ... and nearly 75 for males. The gap in life expectancy between ...
... in birds with the avian virus that have infected human ... strains// of bird flu. ,The research has been ... which illustrates the genetic changes required for the H5N1 avian ... receptors on human cells. ,Yoshihiro Kawaoka, the senior ...
... genetic disorder, know that they shouldn't smoke or be ... developing emphysema at a young age. In addition, a ... (AT) deficiency could develop serious liver injuries due to ... ,A new research performed at Washington University School of ...
... helps them alleviate symptoms like forgetting, distracted, impulsive or ... Columbia University Medical Center// investigates whether these symptoms of ... smoke. ,If that is the case, ... to help people quit smoking – the patch with ...
... childcare worker should be trained in how to handle ... today.// ,'The AMA is calling on all State ... for people who work with children,' Dr Haikerwal said. ... for anaphylactic shock, including how to use auto-injecting devices ...
Cached Medicine News:Health News:A Novel Device System To Reduce Blood Pressure 2Health News:A Novel Device System To Reduce Blood Pressure 3Health News:Scinetists Alert to Onset of Pandemic through Bird flu Mutations to Humans 2Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 2Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 3Health News:A New Study To Examine ADHD's Role In Smoking 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: